To this end, we hypothesized that the binding of cytokines TGF-β1, IL-6, and HGF to their respective receptors induces cancer cells to adopt a mesenchymal metastatic phenotype through the Neu-1-MMP9-GPCR crosstalk signaling platform. The gene discussed is IL6; the disease is cancer.